Walleye Trading’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-600,700
| Closed | -$61M | – | 4292 |
|
|
2025
Q4 | $61M | Buy |
600,700
+537,100
| +844% | +$43.1M | 0.09% | 234 |
|
|
2025
Q3 | $3.48M | Sell |
63,600
-57,800
| -48% | -$2.89M | 0.01% | 1447 |
|
|
2025
Q2 | $6.45M | Buy |
121,400
+59,500
| +96% | +$3.02M | 0.01% | 1067 |
|
|
2025
Q1 | $2.68M | Sell |
61,900
-130,000
| -68% | -$6.58M | 0.01% | 1448 |
|
|
2024
Q4 | $10.8M | Buy |
191,900
+99,700
| +108% | +$6.2M | 0.02% | 750 |
|
|
2024
Q3 | $6.28M | Buy |
92,200
+58,900
| +177% | +$3.32M | 0.01% | 1006 |
|
|
2024
Q2 | $1.41M | Sell |
33,300
-17,100
| -34% | -$941K | ﹤0.01% | 1830 |
|
|
2024
Q1 | $3.48M | Sell |
50,400
-53,400
| -51% | -$3.38M | 0.01% | 1368 |
|
|
2023
Q4 | $7.68M | Sell |
103,800
-4,000
| -4% | -$262K | 0.02% | 936 |
|
|
2023
Q3 | $7.35M | Sell |
107,800
-57,000
| -35% | -$4.84M | 0.02% | 855 |
|
|
2023
Q2 | $15.5M | Buy |
164,800
+15,800
| +11% | +$1.23M | 0.05% | 386 |
|
|
2023
Q1 | $10.1M | Buy |
149,000
+84,700
| +132% | +$5.44M | 0.02% | 627 |
|
|
2022
Q4 | $3.18M | Sell |
64,300
-149,900
| -70% | -$6.12M | 0.01% | 1369 |
|
|
2022
Q3 | $6.96M | Buy |
214,200
+121,800
| +132% | +$5.02M | 0.02% | 810 |
|
|
2022
Q2 | $3.64M | Buy |
92,400
+64,200
| +228% | +$3.43M | 0.01% | 1223 |
|
|
2022
Q1 | $1.97M | Sell |
28,200
-87,000
| -76% | -$6.36M | 0.01% | 1671 |
|
|
2021
Q4 | $8.97M | Buy |
115,200
+40,100
| +53% | +$3.54M | 0.03% | 655 |
|
|
2021
Q3 | $7.17M | Sell |
75,100
-5,300
| -7% | -$560K | 0.03% | 724 |
|
|
2021
Q2 | $9.99M | Buy |
80,400
+77,700
| +2,878% | +$9.27M | 0.04% | 439 |
|
|
2021
Q1 | $356K | Sell |
2,700
-33,800
| -93% | -$4.63M | ﹤0.01% | 3044 |
|
|
2020
Q4 | $4.84M | Buy |
36,500
+13,200
| +57% | +$1.6M | 0.02% | 758 |
|
|
2020
Q3 | $2.38M | Sell |
23,300
-66,600
| -74% | -$5.75M | 0.01% | 1010 |
|
|
2020
Q2 | $7.82M | Buy |
89,900
+56,100
| +166% | +$4.48M | 0.05% | 362 |
|
|
2020
Q1 | $1.96M | Sell |
33,800
-38,100
| -53% | -$3.09M | 0.02% | 841 |
|
|
2019
Q4 | $6.65M | Sell |
71,900
-56,700
| -44% | -$4.98M | 0.05% | 434 |
|
|
2019
Q3 | $11.6M | Sell |
128,600
-34,200
| -21% | -$3.9M | 0.1% | 159 |
|
|
2019
Q2 | $19.2M | Buy |
162,800
+3,200
| +2% | +$322K | 0.17% | 83 |
|
|
2019
Q1 | $13.8M | Buy |
159,600
+109,600
| +219% | +$9.33M | 0.11% | 163 |
|
|
2018
Q4 | $3.15M | Buy |
50,000
+8,900
| +22% | +$611K | 0.02% | 733 |
|
|
2018
Q3 | $3.24M | Sell |
41,100
-74,200
| -64% | -$4.84M | 0.02% | 930 |
|
|
2018
Q2 | $6.89M | Buy |
115,300
+35,700
| +45% | +$1.92M | 0.04% | 450 |
|
|
2018
Q1 | $3.21M | Buy |
79,600
+77,200
| +3,217% | +$3.77M | 0.02% | 811 |
|
|
2017
Q4 | $126 | Sell |
2,400
-34,500
| -93% | -$1.84M | ﹤0.01% | 3727 |
|
|
2017
Q3 | $1.74K | Buy |
36,900
+30,000
| +435% | +$1.21M | 0.01% | 1393 |
|
|
2017
Q2 | $245 | Buy |
6,900
+3,100
| +82% | +$95.7K | ﹤0.01% | 2966 |
|
|
2017
Q1 | $90 | Buy |
3,800
+2,700
| +245% | +$53.5K | ﹤0.01% | 3463 |
|
|
2016
Q4 | $15K | Buy |
+1,100
| New | +$17.8K | ﹤0.01% | 4180 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
Walleye Trading's EXAS Position: Q1 2026 in Review
Walleye Trading sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,000 shares — an estimated $305K sold.
Walleye Trading first reported a position in EXAS in Q1 2018 and held it in 23 quarters. The position peaked at $13M in Q4 2019. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Walleye Trading reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Walleye Trading sold 3,000 Exact Sciences shares in Q1 2026, an estimated $305K.
- Walleye Trading first reported a position in Exact Sciences in Q1 2018 and held it in 23 quarters.
- Walleye Trading's Exact Sciences position peaked at $13M in Q4 2019.
- 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.